Keywords: ares-serono, earnings, beat, expectations, switzerland-based, reported, net
Ares-Serono's earnings beat expectations
Article | 11 March 1999
Switzerland-based Ares-Serono has reported net income of $76.2 millionfor 1998, a decrease of 13.2%, though up 29.1% excluding restructuring and one-time charges which reflect ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
